Skip to content

US · THW · ASSET MANAGEMENT

Abrdn World Healthcare Fund (THW) intrinsic value and stock valuation

$11.83as of 2026-11-21 · Mkt cap 551.11M

Data updated · price as of 2026-11-21

Strongly undervaluedIC value is more than 50% above the price. The exact IC value, upside and the fair-value band are available with Pro.
P/E
Pro
P/B
Pro
P/S
Pro

Price history

Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.

Abrdn World Healthcare Fund DCF and intrinsic value

InvestorsCraft values THW with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from THW’s statements →

Abrdn World Healthcare Fund Graham Number

Graham Number: $20.64d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →

Financial Services · Asset Management Philadelphia, PA 19103 teklacap.com

How the business is doing

Fiscal 2015–2025, USD

Revenue
$63.1M+0.3% 5y CAGRd
20152025
Net income
$55.4M-1.9% 5y CAGRd
20152025
Free cash flow
$34.1M-2.2% 5y CAGRd
20162025
Total equity
$512.5M+3.7% 5y CAGRd
20152025

Is it expensive?

Each multiple against its own 15-year range, or against peers where no history is available

P/E
Pro
with Pro
P/B
Pro
with Pro
P/S
Pro
with Pro
EV/EBITDA
Pro
with Pro
P/EG
Pro
with Pro
P/TBV
Pro
with Pro

Peers

Same-industry companies, ranked by market cap

Peer comparison

The peer comparison table is shown only to users with a Pro subscription.

Financials

Statements by fiscal year

Fiscal 2015–2025, USD
20252024202320222021
Revenue$63.1M$94.5M$46M$38.1M$86.5M
Operating income$55.4M$101.3M$44.5M-$-60.71M$86.3M
Net income$55.4M$93.4M$37.6M-$-62.84M$85.1M
EPSd$1.43M$2.44M$1.01M-$-1.67M$2.29M
Operating cash flow$34.1M$49.6M$44.8M$48.5M-$-55.34M
Capital expenditure$0.00$0.00-$0.00-$0.00$0.00
Free cash flow$34.1M$49.6M$44.8M$48.5M-$-55.34M
Total assets$636.7M$614.3M$569.7M$582.9M$714.2M
Total debt$121.3M$120.1M$120M$120M$120M
Net debt$120.8M-$0.00$120M$120M$120M
Total equity$512.5M$491.2M$447.1M$454.3M$565.7M
Cash and short-term investments$490K$31.6M$19.9M$18.6M$34.6M
Income statement
20252024202320222021
Revenue$63.1M$94.5M$46M$38.1M$86.5M
Cost of revenue$6.88M$7.99M$6.86M$7.52M$7.09M
Gross profit$56.3M$94.5M$39.1M$30.6M$79.4M
Research and development expenses$0.00$0.00$0.00$0.00$0.00
Selling, general and administrative expenses$860K$1.09M$1.06M$1.24M$1.05M
Other expenses$10K$40K$330K$350K$350K
Operating expenses$870K$1.13M$1.4M$1.59M$1.4M
Cost and expenses$7.76M$1.13M$1.41M$98.8M$1.4M
Interest income$3.36M$4.38M$2.49M$2.36M$2.31M
Interest expense$6.88M$7.99M$6.99M$2.05M$1.14M
Depreciation and amortization$0.00$0.00$30K$230K$240K
Ebitda$55.4M$101.3M$44.6M-$-60.48M$86.6M
Operating income$55.4M$101.3M$44.5M-$-60.71M$86.3M
Total other income/expenses, net-$-6.93M-$-7.98M-$-6.95M-$-2.13M-$-1.19M
Income before tax$55.4M$93.4M$37.6M-$-62.84M$85.1M
Income tax expense$0.00$0.00$0.00$0.00$0.00
Net income$55.4M$93.4M$37.6M-$-62.84M$85.1M
Weighted average shares outstanding$38.7M$38.2M$37.3M$37.5M$37.3M
Weighted average diluted shares outstanding$38.7M$38.2M$37.3M$37.5M$37.3M
Balance sheet
20252024202320222021
Cash and short-term investments$490K$31.6M$19.9M$18.6M$34.6M
Net receivables$1.17M$1.7M$2.62M$3.09M$2.76M
Inventory$0.00$0.00$22.5M$0.00$0.00
Total current assets$1.97M$31.6M$2.63M$3.09M$2.76M
Property, plant and equipment, net$0.00$0.00$0.00$0.00$0.00
Goodwill and intangible assets$0.00$0.00$0.00$0.00$0.00
Long-term investments$460K$610.6M$100K$579.6M$711.4M
Total non-current assets$634.8M$610.6M$566.8M$579.6M$711.4M
Total assets$636.7M$614.3M$569.7M$582.9M$714.2M
Accounts payable$2.5M$520K$1.58M$760K$22.4M
Short-term debt$0.00$120.1M$120M$120M$120M
Deferred revenue$0.00$0.00$0.00-$-119.24M-$-97.63M
Total current liabilities$2.5M$700K$1.58M$760K$22.4M
Long-term debt$121.3M$121.5M$120M$120M$120M
Deferred revenue, non-current$0.00$0.00$0.00$0.00$0.00
Total non-current liabilities$121.7M$122.6M$120M$120M$120M
Capital lease obligations$0.00$0.00$0.00$0.00$0.00
Total liabilities$124.2M$123.1M$122.6M$128.6M$148.5M
Common stock$400K$380K$380K$380K$370K
Retained earnings$53.9M$30.6M-$-56.72M-$-63.93M$30M
Accumulated other comprehensive income (loss)$0.00$0.00$0.00$0.00$0.00
Total equity$512.5M$491.2M$447.1M$454.3M$565.7M
Total investments$460K$642.2M$20M$598.2M$746M
Total debt$121.3M$120.1M$120M$120M$120M
Net debt$120.8M-$0.00$120M$120M$120M
Cash flow statement
20252024202320222021
Net income$55.4M$93.4M$37.6M-$-62.84M$85.1M
Depreciation and amortization$0.00$0.00$0.00$0.00$0.00
Stock-based compensation$0.00$0.00$0.00$0.00$0.00
Change in working capital$100K-$-240K$380K$540K$80K
Accounts receivable$250K-$-140K$0.00-$-40K-$-100K
Inventory$0.00$0.00$0.00$0.00$0.00
Accounts payable$0.00$0.00$0.00$0.00$0.00
Net cash provided by operating activities-$-3.33M$49.6M$44.8M$48.5M-$-55.34M
Investments in property, plant and equipment$0.00$0.00$0.00$0.00$0.00
Acquisitions, net$0.00$0.00$0.00$0.00$0.00
Net cash used for investing activities$10.4M$0.00$55.9M$28.7M-$-38.78M
Common stock issued$18.3M$130K$3.95M$0.00$98.8M
Common stock repurchased$0.00$0.00$0.00$0.00$0.00
Dividends paid-$-51.81M-$-49.85M-$-48.79M-$-48.5M-$-44.82M
Net cash used for financing activities-$-33.64M-$-49.61M-$-44.84M-$-48.5M$54M
Net change in cash$490K-$0.00$0.00-$-40K-$-1.33M
Cash at end of period$490K$0.00$0.00$0.00$40K
Operating cash flow$34.1M$49.6M$44.8M$48.5M-$-55.34M
Capital expenditure$0.00$0.00-$0.00-$0.00$0.00
Free cash flow$34.1M$49.6M$44.8M$48.5M-$-55.34M
USD millions

Line items

    USD millions

    Line items

      USD millions

      Line items

        About Abrdn World Healthcare Fund

        Under the stewardship of Tekla Capital Management LLC, the Tekla World Healthcare Fund functions as a balanced, closed-end mutual fund. Its investment mandate extends to publicly traded stocks and debt instruments spanning international markets. A primary focus for its equity allocations is businesses within the healthcare industry, while the debt component of its portfolio largely comprises corporate bonds. Established on June 26, 2015, this fund is headquartered in the United States.

        CEO
        William R. Hite
        Employees
        0
        Beta
        0.81

        Explore

        Frequently asked questions

        What is the intrinsic value of Abrdn World Healthcare Fund (THW)?

        Abrdn World Healthcare Fund (THW) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.

        Is THW undervalued?

        THW trades at a price of $11.83 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.

        How is the intrinsic value calculated?

        InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.

        How often is this page updated?

        Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.

        Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.